Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$2.22 - $6.7 $170,089 - $513,333
76,617 Added 31.8%
317,517 $705,000
Q1 2022

May 16, 2022

BUY
$4.18 - $13.39 $81,714 - $261,761
19,549 Added 8.83%
240,900 $1.49 Million
Q4 2021

Feb 14, 2022

BUY
$11.35 - $97.17 $2.33 Million - $20 Million
205,341 Added 1282.58%
221,351 $2.79 Million
Q3 2021

Nov 15, 2021

BUY
$52.0 - $120.21 $598,000 - $1.38 Million
11,500 Added 254.99%
16,010 $1.47 Million
Q2 2021

Aug 16, 2021

BUY
$31.88 - $58.66 $143,778 - $264,556
4,510 New
4,510 $239,000
Q4 2020

Feb 16, 2021

SELL
$27.78 - $56.93 $359,084 - $735,877
-12,926 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$39.85 - $57.3 $605,401 - $870,501
-15,192 Reduced 54.03%
12,926 $646,000
Q2 2020

Aug 14, 2020

BUY
$34.93 - $57.75 $522,063 - $863,131
14,946 Added 113.47%
28,118 $1.3 Million
Q1 2020

May 15, 2020

BUY
$29.01 - $72.51 $382,119 - $955,101
13,172 New
13,172 $601,000

Others Institutions Holding CRTX

About Cortexyme, Inc.


  • Ticker CRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,150,800
  • Market Cap $70.5M
More about CRTX
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.